BCL2 and diabetic kidney disease: Our study showed that treatment with celastrol significantly increased the renal gene and tissue expression of the antiapoptotic marker, Bcl-2, along with a decreased renal gene and tissue expression of the proapoptotic marker, caspase-3, compared with the DKD group.